TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Free Report) – Research analysts at HC Wainwright reduced their FY2025 earnings per share estimates for shares of TRACON Pharmaceuticals in a report released on Wednesday, April 3rd. HC Wainwright analyst E. White now expects that the biopharmaceutical company will earn ($0.27) per share for the year, down from their […]
Bleakley Financial Group LLC grew its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 10.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 8,977 shares of the biopharmaceutical company’s stock after buying an additional 860 shares during the period. Bleakley Financial Group LLC’s holdings in Regeneron Pharmaceuticals were worth […]
Strategic Blueprint LLC Acquires 106 Shares of Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) dropped 3.6% during mid-day trading on Monday . The stock traded as low as $14.78 and last traded at $14.79. Approximately 55,852 shares changed hands during trading, a decline of 89% from the average daily volume of 530,911 shares. The stock had previously closed at $15.34. Analysts […]
Trifecta Capital Advisors LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3,625.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,533 shares of the biopharmaceutical company’s stock after purchasing an additional 2,465 shares during the […]